Reaction
Helicobacter Gastritis reporting signals
As of the last recalculation, Helicobacter Gastritis appears in 1,232 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is OLMESARTAN MEDOXOMIL (PRR 41.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Olmesartan Medoxomil | 82 | 41.2 | 41.3 |
| Clarithromycin | 50 | 25.6 | 25.6 |
| Telmisartan | 24 | 23.1 | 23.2 |
| Linagliptin | 24 | 22.7 | 22.7 |
| Esomeprazole Magnesium Capsule, Delayed Release | 19 | 22.5 | 22.5 |
| Esomeprazole Magnesium Delayed Release Capsules | 19 | 22.5 | 22.5 |
| Esomeprazole Magnesium Dihydrate | 19 | 22.4 | 22.4 |
| Moxifloxacin | 11 | 13.3 | 13.3 |
| Pyrazinamide | 6 | 10.8 | 10.8 |
| Clopidogrel Bisulfate | 62 | 10.7 | 10.7 |
| Azelastine | 10 | 9.5 | 9.5 |
| Brimonidine Tartrate | 9 | 8.6 | 8.6 |